TCR-T cells
LTCR-HCC-2-2
Phase 1 mab active
Quick answer
TCR-T cells for Recurrent Hepatocellular Carcinoma is a Phase 1 program (mab) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Recurrent Hepatocellular Carcinoma
- Phase
- Phase 1
- Modality
- mab
- Status
- active